Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Bioglutide (NA-931) Phase 2: 13.8% Oral Weight Loss The Phase 2 trial reported oral quadruple agonist NA-931 hit 13.8% weight loss with no muscle loss
[updated 2023 Jul 30
CJC-1295, Ipamorelin, Sermorelin, IGF-1 LR3 and secretagogue reference compounds
Moderate caloric restriction (15-20% below maintenance) supports AOD-9604 protocols without triggering metabolic adaptation or excessive muscle loss
US$ 23.47
US$ 26.72
US$ 25.37
US$ 25.15
US$ 26.09
US$ 28.32
US$ 21.57
US$ 21.00
